The Pennant Group, Inc. (PNTG) Q2 Earnings and Revenues Surpass Estimates

Group 1 - The Pennant Group, Inc. reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.26 per share, and showing an increase from $0.24 per share a year ago, resulting in an earnings surprise of +3.85% [1] - The company achieved revenues of $219.5 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.16%, and up from $168.74 million year-over-year [2] - The Pennant Group has outperformed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates four times in the same period [2] Group 2 - The stock has underperformed the market, losing about 16.3% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $0.28 on revenues of $215.51 million, and for the current fiscal year, it is $1.11 on revenues of $856.91 million [7] Group 3 - The Medical - Outpatient and Home Healthcare industry, to which The Pennant Group belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for The Pennant Group was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]